Navigation Links
Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan
Date:3/11/2010

DUBLIN, March 11, 2010 /PRNewswire/ -- Azur Pharma Limited ("Azur") today announced it has signed a definitive agreement with Elan Pharmaceuticals, Inc. (a subsidiary of Elan Corporation, plc) ( ELN) ("Elan") to acquire the analgesic therapy, PRIALT(R) (ziconotide intrathecal infusion).

PRIALT is indicated in the United States for the management of severe chronic pain in patients for whom intrathecal ("IT") therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or IT morphine. PRIALT was approved by the U.S. Food and Drug Administration ("FDA") in December 2004 and launched in January 2005.

Azur has agreed to acquire worldwide rights (other than Europe) to PRIALT. Azur will offer employment to a 34 person specialty pharmaceutical infrastructure, which is currently supporting the product at Elan. End-user sales of PRIALT in the U.S. were approximately $20 million and $18 million in 2009 and 2008, respectively.

Mr. Seamus Mulligan, Ch
'/>"/>

Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
5. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... In a sneak preview of the ... technologies with applications in multiple and diverse areas ... and Photonics symposium in San Diego, California, ... society for optics and photonics , the event ... technology meeting in North America, with approximately 4,500 ...
(Date:5/24/2013)... Israel , May 24, 2013 ... leader in embolic protection stents, announced that Alan ... and Craig Shore , the Company,s Chief ... Investor Conference on Thursday May 30, 2013 at The Pfister ... The format of the conference includes a ...
(Date:5/24/2013)... Texas (PRWEB) May 24, 2013 ... benchmarking survey on kinase profiling carried out in ... details of the breakdown of the responses for ... the future (2015). It also highlights some interesting ... survey groupings. Two bottom-up models were developed to ...
(Date:5/24/2013)... City, OK (PRWEB) May 24, 2013 The ... of casualties. And following its ravage, the mayor of Moore, ... bill for new houses, said a report from cnn.com. Reaching ... the tornado victims complimentary Molderizer and Safe Shield to counter ... to the report published on May 22, 2013, caused 24 ...
Breaking Biology Technology:See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 2See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 3See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 4InspireMD To Participate In Benchmark Investor Conference On May 30th 2InspireMD To Participate In Benchmark Investor Conference On May 30th 3InspireMD To Participate In Benchmark Investor Conference On May 30th 4Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4Mayor of Oklahoma-Tornado-Impaired Town Proposes Storm Shelter Bill, My Cleaning Products Offers Complimentary Molderizer and Safe Shield to Help Victim with Looming Mold 2
... LifeStem,International, Inc., (OTC Bulletin Board: LSTM), formerly CalbaTech, ... products and,platforms to the research market for biotech ... as providing services in the,collection, processing and storage ... first quarter of 2008 ending March 31 totaled ...
... Injuries Believed to be Caused by Contaminated Blood ... thinner Heparin continues to,make headlines as more people ... after using the contaminated drug -- a group ... Friday, May 2, 2008, another lawsuit,was filed against ...
... At their 2008 Annual,Meeting, shareholders of Spherix Incorporated (Nasdaq: SPEX ... -- Douglas T. Brown, Senior VP and Manager of Corporate Banking ... Paul Cox, Jr., Principal, Asset Protection Company -- Claire L. ... Spherix -- Gilbert V. Levin, Ph.D., Director of Science ...
Cached Biology Technology:LifeStem International, Inc. Announces Increased Revenues, Decreased Operating Expenses 2LifeStem International, Inc. Announces Increased Revenues, Decreased Operating Expenses 3Illinois Pharmaceutical Manufacturer Sued for Injuries to Kentucky Resident 2Illinois Pharmaceutical Manufacturer Sued for Injuries to Kentucky Resident 3Spherix Holds Annual Shareholders Meeting 2
(Date:5/23/2013)... which estrogen suppresses lipid synthesis in the liver, UC ... treating certain liver diseases. , With this finding, ... long-held views in the field. Study results appear in ... Signaling . , "The dogma in the steroid receptor ... located in the nucleus respond to steroid hormones by ...
(Date:5/23/2013)... the overall health, development, and academic success of ... ensuring that all students have opportunities to engage ... vigorous or moderate-intensity physical activity, says a new ... estimates suggest that only about half of school-age ... health and development. The report recommends that ...
(Date:5/23/2013)... (May 23, 2013) A new report from ... for helping pupils engage in at least 60 minutes ... day. , No more than half of American youth ... of vigorous or moderate intensity physical activity daily, according ... "Because children are in school for nearly half of ...
Breaking Biology News(10 mins):UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 3Schools should provide students with daily physical activity, IOM recommends 2
... A Leicester cancer research project, which receives funding ... is investigating whether an extract from bilberries can ... Professor Andy Gescher, of the University of ... out clinical trials with the commercially produced substance ...
... help reduce the risk of pancreatic cancer, says a ... naturally in apples and onions, has been identified as ... reducing the risk of pancreatic cancer. Although the ... who consumed foods rich in flavonols had a significantly ...
... CLEMSON Energy lost from hot engines could ... captured and converted into electricity via thermoelectric devices, ... in Dallas for the world-renowned NanoTX 07 conference. ... MacDairmid Memorial Nano Energy Summit on challenges in ...
Cached Biology News:Bilberry extract -- can it help prevent certain cancers? 2Bilberry extract -- can it help prevent certain cancers? 3Naturally-occurring apple compounds reduce risk of pancreatic cancer 2Clemson physicist addresses international forum on thermoelectric energy 2
... chambers with forced convection Temperature range 5 ... 99.9 C / 212 F Patented APT.line ... DS controller Timer 0 to 24 ... of a tenth of a degree Independent ...
... the value of your microarray data ... the support you need from consultation ... most up to date methods. Utilize ... Gene Expression Profiling Service or from ...
Formula variant: With macro- and micronutrients. Physical Form: powder Suitab tst: plant cell culture tested...
... Mass Analyzer for superior sensitivity, mass accuracy, and resolving power., ... Precursor ion selection range: 150 - 4000 m/z, * Resolution: 14,000 ... reference, * Dynamic range: 4 orders of magnitude ... ...
Biology Products: